Quarter revenue and profit surge; limited review unmodified

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults restatedResults View source PDF Explain this filing

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹178.99

prior close

₹179.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-1.0% vs market

Pharmaceuticals peers, median of 174sector+0.2%+0.3% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.2

10m

-1.3

15m

-0.6

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+1.4-1.0+0.2+0.3

Next day

-3.2+1.7-4.9+0.6-3.9

+3.3+3.9-0.6+1.6+1.7

+5.3+5.1+0.2+2.3+3.0

+3.0pendingpending+2.2+0.8

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Quarter revenue from operations rose 40.1% to Rs 795.03 crore from Rs 567.53 crore, while profit after tax jumped 116.8% to Rs 65.03 crore from Rs 30 crore. Half-year revenue rose 38.6% to Rs 1,551.29 crore and profit after tax doubled to Rs 129.51 crore. The limited review was unmodified. Half-year operating cash flow was Rs 8.29 crore; capital spending was Rs 141.32 crore. Prior-period figures were regrouped or restated where needed.

Likely market impact

Strong revenue and profit growth may support the stock, but low operating cash flow and heavy capital spending warrant caution.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹795.0 Cr	₹567.5 Cr	+40.1%
Operating profit	₹81.78 Cr	₹33.61 Cr	+143.3%
Profit after tax	₹65.07 Cr	₹29.97 Cr	+117.1%
EBITDA margin	13.8%	10.1%	+3.7 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.